股票简称：丰原药业           股票代码：000153          公告编号：2014—031     

                          安徽丰原药业股份有限公司关于重大资产重组                      

                              拟收购标的公司通过药品GMP认证的公告                    

                     本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误           

                导性陈述或者重大遗漏。    

                     根据国家食品药品监督管理总局发布的药品GMP认证公告（第20号），本公                

                司重大资产重组拟收购的标的公司成都普什制药有限公司已通过国家食品药品监             

                督管理总局药品GMP认证。具体情况如下：           

                                                                               有效期至

                  证书编号    企业名称     地址     认证范围   认证日期   （认证日    发证机关

                                                                              期后五年） 

                                                      小容量注

                              成都普什   成都高新  射剂（非最                            国家食品

                                                                  2014年4    2019年4 

                CN20140173   制药有限   西区西部   终灭菌，                             药品监督

                                                                   月10日      月9日 

                                公司        园区     BFS塑料                             管理总局

                                                     安瓿1#线） 

                     特此公告。  

                                                                       安徽丰原药业股份有限公司    

                                                                               董  事  会

                                                                         二○一四年四月十五日